Assessment of Dietary Sodium Intake Using the Scored Salt Questionnaire in Autosomal Dominant Polycystic Kidney Disease
- PMID: 33147804
- PMCID: PMC7692491
- DOI: 10.3390/nu12113376
Assessment of Dietary Sodium Intake Using the Scored Salt Questionnaire in Autosomal Dominant Polycystic Kidney Disease
Abstract
The excess intake of dietary sodium is a key modifiable factor for reducing disease progression in autosomal dominant polycystic kidney disease (ADPKD). The aim of this study was to test the hypothesis that the scored salt questionnaire (SSQ; a frequency questionnaire of nine sodium-rich food types) is a valid instrument to identify high dietary salt intake in ADPKD. The performance of the SSQ was evaluated in adults with ADPKD with an estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73 m2 during the screening visit of the PREVENT-ADPKD trial. High dietary sodium intake (HSI) was defined by a mean 24-h urinary sodium excretion ≥ 100 mmol/day from two collections. The median 24-h urine sodium excretion was 132 mmol/day (IQR: 112-172 mmol/d) (n = 75; mean age: 44.6 ± 11.5 years old; 53% female), and HSI (86.7% of total) was associated with male gender and higher BMI and systolic blood pressure (p < 0.05). The SSQ score (73 ± 23; mean ± SD) was weakly correlated with log10 24-h urine sodium excretion (r = 0.29, p = 0.01). Receiving operating characteristic analysis showed that the optimal cut-off point in predicting HSI was an SSQ score of 74 (area under the curve 0.79; sensitivity 61.5%; specificity 90.0%; p < 0.01). The evaluation of the SSQ in participants with a BMI ≥ 25 (n = 46) improved the sensitivity (100%) and the specificity (100%). Consumers with an SSQ score ≥ 74 (n = 41) had higher relative percentage intake of processed meats/seafood and flavourings added to cooking (p < 0.05). In conclusion, the SSQ is a valid tool for identifying high dietary salt intake in ADPKD but its value proposition (over 24-h urinary sodium measurement) is that it may provide consumers and their healthcare providers with insight into the potential origin of sodium-rich food sources.
Keywords: 24-h urine; autosomal dominant polycystic kidney disease; diet; food frequency questionnaire; progression; salt; sodium.
Conflict of interest statement
G. Rangan receives research grant support from Danone Research, Otsuka Pharmaceuticals and has been a site investigator for clinical trials sponsored by Sanofi, Reata Pharmaceuticals. G. Rangan also receives grant support from NHMRC and PKD Australia. D. Johnson has received consultancy fees, research grants, speaker’s honoraria and travel sponsorships from Baxter Healthcare and Fresenius Medical Care, consultancy fees from Astra Zeneca and AWAK, speaker’s honoraria and travel sponsorships from ONO, and travel sponsorships from Amgen. He is a current recipient of an Australian National Health and Medical Research Council Practitioner Fellowship. The authors have no other relevant affiliations or financial involvement with any organisation or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Figures




Similar articles
-
Development and validation of a dietary screening tool for high sodium consumption in Australian renal patients.J Ren Nutr. 2014 Mar;24(2):123-34.e1-3. doi: 10.1053/j.jrn.2013.10.004. Epub 2014 Jan 3. J Ren Nutr. 2014. PMID: 24394445
-
Sodium and urea excretion as determinants of urine output in autosomal dominant polycystic kidney disease patients on V2 receptor antagonists: impact of dietary intervention.Int Urol Nephrol. 2020 Feb;52(2):343-349. doi: 10.1007/s11255-020-02384-3. Epub 2020 Feb 1. Int Urol Nephrol. 2020. PMID: 32008201
-
Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.Kidney Int. 2017 Feb;91(2):493-500. doi: 10.1016/j.kint.2016.10.018. Epub 2016 Dec 16. Kidney Int. 2017. PMID: 27993381 Free PMC article. Clinical Trial.
-
Nutritional therapy in autosomal dominant polycystic kidney disease.J Nephrol. 2018 Oct;31(5):635-643. doi: 10.1007/s40620-018-0470-x. Epub 2018 Jan 17. J Nephrol. 2018. PMID: 29344814 Review.
-
Development of a Patient-Reported Outcomes Tool to Assess Pain and Discomfort in Autosomal Dominant Polycystic Kidney Disease.Clin J Am Soc Nephrol. 2023 Feb 1;18(2):213-222. doi: 10.2215/CJN.0000000000000034. Epub 2023 Jan 2. Clin J Am Soc Nephrol. 2023. PMID: 36754008 Free PMC article. Review.
Cited by
-
Family Self-management Program for Hypertension Management and Sodium Consumption Adherence: A Parallel Randomized Control Trial Among Family Caregivers and People With Hypertension.J Res Health Sci. 2024 Sep 30;24(4):e00628. doi: 10.34172/jrhs.2024.163. Epub 2024 Sep 30. J Res Health Sci. 2024. PMID: 39431653 Free PMC article. Clinical Trial.
-
Cardiovascular Manifestations and Management in ADPKD.Kidney Int Rep. 2023 Aug 4;8(10):1924-1940. doi: 10.1016/j.ekir.2023.07.017. eCollection 2023 Oct. Kidney Int Rep. 2023. PMID: 37850017 Free PMC article. Review.
-
Sodium Intake Estimation in Chronic Kidney Disease: From Measurement Methods to Clinical Outcomes.Turkish J Nephrol. 2025 Jul;34(3):160-168. doi: 10.5152/turkjnephrol.2025.25922. Epub 2025 Jul 1. Turkish J Nephrol. 2025. PMID: 40689358 Free PMC article.
References
-
- Torres V.E., Abebe K.Z., Schrier R.W., Perrone R.D., Chapman A.B., Yu A.S., Braun W.E., Steinman T.I., Brosnahan G., Hogan M.C., et al. Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease. Kidney Int. 2017;91:493–500. doi: 10.1016/j.kint.2016.10.018. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous